Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

Adenovirus Type 35 Based Circumsporozoite Malaria Vaccine in Burkina Faso

This study has been completed.
Sponsor:
Information provided by (Responsible Party):
National Institute of Allergy and Infectious Diseases (NIAID)
ClinicalTrials.gov Identifier:
NCT01018459
First received: November 19, 2009
Last updated: June 5, 2014
Last verified: February 2012